Granules India Limited Reports Unaudited Consolidated and Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2016
January 28, 2017 at 12:15 pm
Share
Granules India Limited reported unaudited consolidated and standalone earnings results for the third quarter and nine months ended December 31, 2016. For the quarter on consolidated basis, the company reported total income from operations of INR 3,594.733 million against INR 3,249.941 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 576.320 million against INR 507.135 million a year ago. Profit from ordinary activities before tax was INR 535.401 million against INR 416.703 million a year ago. Net profit for the period was INR 359.111 million or INR 1.77 per share diluted against INR 287.526 million or INR 1.35 per share diluted a year ago.
For the nine months on consolidated basis, the company reported total income from operations of INR 10,730.798 million against INR 10,071.366 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 1,655.243 million against INR 1,534.976 million a year ago. Profit from ordinary activities before tax was INR 1,521.182 million against INR 1,299.266 million a year ago. Net profit for the period was INR 1,035.080 million or INR 5.40 per share diluted against INR 893.533 million or INR 4.17 per share diluted a year ago.
For the quarter on standalone basis, the company reported total income from operations of INR 3,373.759 million against INR 3,243.415 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 547.247 million against INR 535.264 million a year ago. Profit from ordinary activities before tax was INR 520.715 million against INR 448.414 million a year ago. Net profit for the period was INR 352.867 million or INR 1.60 per share diluted against INR 304.263 million or INR 1.41 per share diluted a year ago.
For the nine months on standalone basis, the company reported total income from operations of INR 10,223.982 million against INR 9,958.911 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 1,620.753 million against INR 1,522.574 million a year ago. Profit from ordinary activities before tax was INR 1,519.593 million against INR 1,292.562 million a year ago. Net profit for the period was INR 1,043.787 million or INR 4.74 per share diluted against INR 875.652 million or INR 4.06 per share diluted a year ago.
Granules India Limited is an India-based pharmaceutical manufacturing company. The Company operates through its pharmaceuticals products segment. Its geographical segments include within India and outside India. The Company has its presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). It has over eight manufacturing facilities, approximately seven of which are located in India and one in the United States. The Company sells its products in the global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific and India. The Companyâs wholly owned subsidiaries include Granules USA Inc, Granules Pharmaceuticals Inc, Granules Europe Limited and Granules Lifesciences Private Limited.
GRANULES INDIA LIMITED 
